Yangzhou Princechem Co., Ltd.
 
APIs intermediates
Product Name CAS No. Inquiry Online
   Quetiapine
 
   2-(2-chloroethoxy)ethanol 628-89-7
   2-(2-hydroxyethoxy)ethyl)piperazine 13349-82-1
   10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepine 3159--07-7
   Gefitinib
 
   4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol 184475-71-6
   6-hydroxy-7-methoxy-3,4-dihydroquinazolin-4(3H)-one 179688-52-9
   6-acetoxy-7-methoxy-3,4-dihydroquinazolin-4(3H)-one 179688-53-0
   Dasatinib
 
   2-chloro-6-methylaniline 87-63-8
   2-amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302964-24-5
   Sunitinib
 
   5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid 253870-02-9
   Sorafenib
 
   4-chloro-N-methyl-2-pyridinecarboxamide 220000-87-3
   Ezetimibe
 
   4-(((4-Fluorophenyl)imino)methyl)phenol 3382-63-6
   N-(4-(benzyloxy)benzylidene)-4-fluorobenzenamine 70627-52-0
   Pentoxyverine
 
   2-(2-(diethylamino)ethoxy)ethanol 140-82-9
   1-phenylcyclopentanecarboxylic acid 77-55-4
   1-phenylcyclopentane carbonyl chloride 17380-62-0
   Safinamide
 
   4-(3-fluorobenzyloxy)benzaldehyde 66742-57-2
   Flibanserin
 
   1-(2-chloroethyl)-4-[3-(trifluoromethyl)phenyl]piperazine,dihydrochloride 57061-71-9
   Fluvoxamine
 
   1-chloro-4-methoxybutane 17913-18-7
   5-methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone 61718-80-7
   Trazodone
 
   1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride 52605-52-4
   1,2,4-triazole[4,3-a]pyridine-3(2H)-one 6969-71-7
   Aliskiren
 
   methyl 2-cyano-2-methylpropanoate 72291-30-6
   4-bromo-1-methoxy-2-(3-methoxy-propoxy)benzene 173336-76-0
   Telmisartan
 
   methyl 4’-bromomethylbiphenyl-2-carboxylate 114772-38-2
   Flecainide
 
   2,5-bis(2,2,2-trifluoroethoxy)benzoic acid 35480-52-5
   2-aminomethylpiperidine 22990-77-8
 
     Home  |  Introduction  |  Products  |  News  |  Factory  |  Patent  |  Order  |  Contact Us  |  中文版   【Admin
     Copyright(C)2014,Yangzhou Prince Medical Technology Co., Ltd.. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice